Adiponectin in metabolic bone disease

Current Medicinal Chemistry

Volumn 19, Issue 32, 2012, Pages 5481-5492

  Kanazawa, I ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Adiponectin; Bone mineral density; Bone turnover; Fracture risk; Osteoblast; Osteocalcin; Osteoclast; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; CYCLOOXYGENASE 2; MESSENGER RNA; OSTEOPROTEGERIN; PROTEIN C JUN; SMALL INTERFERING RNA; SYNAPTOPHYSIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ARTICLE; BONE FRAGILITY; BONE MARROW; BONE METABOLISM; BONE MINERAL; BONE TISSUE; BONE TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; COMPUTER ASSISTED TOMOGRAPHY; FEMUR; FRACTURE; GLYCEMIC CONTROL; HIP FRACTURE; HYPERINSULINEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LUMBAR SPINE; METABOLIC BONE DISEASE; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK; TIBIA; WESTERN BLOTTING;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BONE AND BONES; BONE DISEASES, METABOLIC; DIABETES MELLITUS, TYPE 2; FRACTURES, BONE; HUMANS; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; RECEPTORS, ADIPONECTIN;

EID: 84870463599     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803833146     Document Type: Article

References (104)

1. Combs, T.P.; Berg, A.H.; Obici, S.; Scherer, P.E.; Rossetti, L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest., 2001, 108; 1875-1881.
2. Berg, A.H.; Combs, T.P.; Du, X.; Brownlee, M.; Scherer, P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med., 2001, 7; 947-953.
3. Weyer, C.; Funahashi, T.; Tanaka, S.; Hotta, K.; Matsuzawa, Y.; Pratley, R.E.; Tataranni, P.A. Hypoadiponectemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 2001, 86; 1930-1935.
4. Scherer, P.E.; Williams, S.; Fogliano, M.; Baldini, G.; Lodish, H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem., 1995, 270; 26746-26749.
5. Maeda, K.; Okubo, K.; Shimomura, I.; Funahashi, T.; Matsuzawa, Y.; Matsubara, K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun., 1996, 221; 286-289.
6. Nakano, Y.; Tobe, T.; Choi-Miura, N.H.; Mazda, T.; Tomita, M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem., 1996, 120; 803-812.
7. Shapiro, L.; Scherer, P.E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol., 1998, 8; 335-340.
8. Kishida, K.; Nagaretani, H.; Kondo, H.; Kobayashi, H.; Tanaka, S.; Maeda, N.; Nagasawa, A.; Hibuse, T.; Ohashi, K.; Kumada, M.; Nishizawa, H.; Okamoto, Y.; Ouchi, N.; Maeda, K.; Kihara, S.; Funahashi, T.; Matsuzawa, Y. Disturbed secretion of mutant adiponectin associated with the metabolic syndrome. Biochem. Biophys. Res. Commun., 2003, 306; 286-292.
9. Yamauchi, T.; Kamon, J.; Ito, Y.; Tsuchida, A.; Yokomizo, T.; Kita, S.; Sugiyama, T.; Miyagishi, M.; Hara, K.; Tsunoda, M.; Murakami, K.; Ohteki, T.; Uchida, S.; Takekawa, S.; Waki, H.; Tsuno, N.H.; Shibata, Y.; Terauchi, Y.; Froguel, P.; Tobe, K.; Koyasu, S.; Taira, K.; Kitamura, T.; Shimizu, T.; Nagai, R.; Kadowaki, T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003, 423; 762-769.
10. Kadowaki, T.; Yamauchi, T.; Kubota, N.; Hara, K.; Ueki, K.; Tobe, K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest., 2006, 116; 1784-1792.
11. Ouchi, N.; Kihara, S.; Arita, Y.; Okamoto, Y.; Maeda, K.; Kuriyama, H.; Hotta, K.; Nishida, M.; Takahashi, M.; Muraguchi, M.; Ohmoto, Y.; Nakamura, T.; Yamashita, S.; Funahashi, T.; Matsuzawa, Y. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation, 2000, 102. 1296-1301.
12. Tsuchida, A.; Yamauchi, T.; Ito, Y.; Hada, Y.; Maki, T.; Takekawa, S.; Kamon, J.; Kobayashi, M.; Suzuki, R.; Hara, K.; Kubota, N.; Terauchi, Y.; Froguel, P.; Nakae, J.; Kasuga, M.; Accili, D.; Tobe, K.; Ueki, K.; Nagai, R.; Kadowaki, T. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem., 2004, 279; 30817-30822.
13. Kadowaki, T.; Yamauchi, T. Adiponectin and adiponectin receptors. Endocr. Rev., 2005, 26; 439-451.
14. Stefan, N.; Machicao, F.; Staiger, H.; Machann, J.; Schick, F.; Tschritter, O.; Spieth, C.; Weigert, C.; Fritsche, A.; Stumvoll, M.; Haring, H.U. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia, 2005, 48; 2282-2291.
15. Yamauchi, T.; Kadowaki, T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int. J. Obes., 2008, 7; S13-8.
16. Dzamko, N.L.; Steinberg, G.R. AMPK-dependent hormonal regulation of whole-body energy metabolism. Acta. Physiol., 2009, 196; 115-127.
17. Fiaschi, T.; Cirelli, D.; Comito, G.; Gelmini, S.; Ramponi, G.; Serio, M.; Chiarugi, P. Globular adiponectin induces differentiation and fusion of skeletal muscle cells. Cell Res., 2009, 19; 584-597.
18. Reid, I.R. Fat and bone. Arch. Biochem. Biophys., 2010, 503; 20-27.
19. Kanazawa, I.; Yamaguchi, T.; Yano, S.; Yamauchi, M.; Yamamoto, M.; Sugimoto, T. Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol., 2007, 8; 51.
20. Berner, H.S.; Lyngstadaas, S.P.; Spahr, A.; Monjo, M.; Thommesen, L.; Drevon, C.A.; Syversen, U. Reseland JE. Adiponectin and its receptors are expressed in bone-forming cells. Bone, 2004, 35; 842-849.
21. Luo, X.H.; Guo, L.J.; Yuan, L.Q.; Xie, H.; Zhou, H.D.; Wu, X.P.; Liao, E.Y. (2005) Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp. Cell Res., 2005, 309; 99-109.
22. Richards, J.B.; Valdes, A.M.; Burling, K.; Perks, U.C.; Spector, T.D. Serum adiponectin and bone mineral density in women. J. Clin. Endocrinol. Metab., 2007, 92; 1517-1523.
23. Peng, X.D.; Xie, H.; Zhao, Q.; Wu, X.P.; Sun, Z.Q.; Liao, E.Y. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clinica. Chimica. Acta., 2008, 387; 31-35.
24. Kanazawa, I.; Yamaguchi, T.; Yamamoto, M.; Yamauchi, M.; Yano, S.; Sugimoto, T. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol., 2009, 160; 265-273.
25. Confavreux, C.B.; Levine, R.L.; Karsenty, G. A paradigm of integrative physiology, the crosstalk between bone and energy metabolism. Mol. Cell Endocrinol., 2009, 310; 21-29.
26. Lee, N.K.; Sowa, H.; Hinoi, E.; Ferron, M.; Ahn, J.D.; Confavreux, C.; Dacquin, R.; Mee, P.J.; McKee, M.D.; Jung, D.Y.; Zhang, Z.; Kim, J.K.; Mauvais-Jarvis, F.; Ducy, P.; Karsenty, G. Endocrine regulation of energy metabolism by the skeleton. Cell, 2007, 130; 456-469.
27. Ferron, M.; Hinoi, E.; Karsenty, G.; Ducy, P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc. Natl. Acad. Sci. U.S.A., 2008, 105; 5266-5270.
28. Yokota, T.; Meka, C.S.; Kouro, T.; Medina, K.L.; Igarashi, H.; Takahashi, M.; Oritani, K.; Funahashi, T.; Tomiyama, Y.; Matsuzawa, Y.; Kincade, P.W. Adiponectin, a fat cell product, influences the earliest lymphocyte precursors in bone marrow cultures by activation of the cyclooxygenaseprostaglandin pathway in stromal cells. J. Immunol., 2003, 171; 5091-5099.
29. Shinoda, Y.; Yamaguchi, M.; Ogata, N.; Akune, T.; Kubota, N.; Yamauchi, T.; Terauchi, Y.; Kadowaki, T.; Takeuchi, Y.; Fukumoto, S.; Ikeda, T.; Hoshi, K.; Chung, U.; Nakamura, K.; Kawaguchi, H. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J. Cell Biochem., 2006, 99; 196-208.
30. Luo, X.H.; Guo, L.J.; Xie, H.; Yuan, L.Q.; Wu, X.P.; Zhou, H.D.; Liao, E.Y. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J. Bone Miner. Res., 2006, 21; 1648-1656.
31. Williams, G.A.; Wang, Y.; Callon, K.E.; Watson, M.; Lin, J.M.; Lam, J.B.; Costa, J.L.; Orpe, A.; Broom, N.; Naot, D.; Reid, I.R.; Cornish, J. In vitro and in vivo effects of adiponectin on bone. Endocrinology, 2009, 150; 3603-3610.
32. Kanazawa, I.; Yamaguchi, T.; Yano, S.; Yamauchi, M.; Sugimoto, T. Activation of AMP-kinase and inhibition of Rho-kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression. Am. J. Physiol. Endocrinol. Metab., 2009, 296; E139-146.
33. Oshima, K.; Nampei, A.; Matsuda, M.; Iwaki, M.; Fukuhara, A.; Hashimoto, J.; Yoshikawa, H.; Shimomura, I. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem. Biophys. Res. Commun., 2005, 331; 520-526.
34. Kanazawa, I. AMPK regulates bone morphogenetic protein-2 expression in osteoblast. In: Bone Morphogenetic Proteins: New Research; Anja Nohe, Ed.; Nova Science Publishers, Inc., 2012, pp. 203-214.
35. Huang, C.Y.; Lee, C.Y.; Chen, M.Y.; Tsai, H.C.; Hsu, H.C.; Tang, C.H. Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. J. Cell. Physiol., 2010, 224; 475-483.
36. Lee, H.W.; Kim, S.Y.; Kim, A.Y.; Lee, E.J.; Choi, J.Y.; Kim, J.B. Adiponectin stimulates osteoblast differentiation through induction of COX2 in mesenchymal progenitor cells. Stem Cells, 2009, 27; 2254-2262.
37. Tu, Q.; Zhang, J.; Dong, L.Q.; Saunders, E.; Luo, E.; Tang, J.; Chen, J. Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J. Biol. Chem., 2011, 286; 12542-12553.
38. Yamaguchi, N.; Kukita, T.; Li, Y.J.; Martinez, Argueta, J.G.; Saito, T.; Hanazawa, S.; Yamashita, Y. Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from actinobacillus actinomycetemcomitans. FEMS Immunol. Med. Microbiol., 2007, 49; 28-34.
39. Yamaguchi, N.; Kukita, T.; Li, Y.J.; Kamio, N.; Fukumoto, S.; Nonaka, K.; Ninomiya, Y.; Hanazawa, S.; Yamashita, Y. Adiponectin inhibits induction of TNF-alpha/RANKL-stimulated NFATc1 via the AMPK signaling. FEBS Lett., 2008, 582; 451-456.
40. Ealey, K.N.; Kaludjerovic, J.; Archer, M.C.; Ward, W.E. Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp. Biol. Med., 2008, 233; 1546-1553.
41. Mitsui, Y.; Gotoh, M.; Fukushiman, N.; Shirachi, I.; Otabe, S.; Yuan, X.; Hashinaga, T.; Wada, N.; Mitsui, A.; Yoshida, T.; Yoshida, S.; Yamada, K.; Nagata, K. Hyperadiponectinema enhances bone formation in mice. BMC Musculoskelet. Disord., 2011, 12; 18.
42. Waki, H.; Yamauchi, T.; Kamon, J.; Ito, Y.; Uchida, S.; Kita, S.; Hara, K.; Hada, Y.; Vasseur, F.; Froguel, P.; Kimura, S.; Nagai, R.; Kadowaki, T. Impaired multimerization of human adiponectin mutants associated with diabetes: Molecular structure and multimer formation of adiponectin. J. Biol. Chem., 2003, 278; 40352-40363.
43. Kubota, N.; Terauchi, Y.; Yamauchi, T.; Kubota, T.; Moroi, M.; Matsui, J.; Eto, K.; Yamashita, T.; Kamon, J.; Satoh, H.; Yano, W.; Froguel, P.; Nagai, R.; Kimura, S.; Kadowaki, T.; Noda, T. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem., 2002, 277; 25863-25866.
44. Fulzele, K.; Riddle, R.C.; Digirolamo, D.J.; Cao, X.; Wan, C.; Chen, D.; Faugere, M.C.; Aja, S.; Hussain, M.A.; Bruning, J.C.; Clemens, T.L. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell, 2010, 142; 309-319.
45. Ferron, M.; Wei, J.; Yoshizawa, T.; Del Fattore, A.; DePinho, R.A.; Teti, A.; Ducy, P.; Karsenty, G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell, 2010, 142; 296-308.
46. Hinoi, E.; Gao, N.; Jung, D.Y.; Yadav, V.; Yoshizawa, T.; Myers, M.G. Jr.; Chua, S.C. Jr.; Kim, J.K.; Kaestner, K.H.; Karsenty, G. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell Biol., 2008, 183; 1235-1242.
47. Oury, F.; Sumara, G.; Sumara, O.; Ferron, M.; Chang, H.; Smith, C.E.; Hermo, L.; Suarez, S.; Roth, B.L.; Ducy, P.; Karsenty, G. Endocrine regulation of male fertility by the skeleton. Cell, 2011, 144; 796-809.
48. Pino, A.M.; Rios, S.; Astudillo, P.; Fernandez, M.; Figueroa, P.; Seitz, G.; Rodriguez, J.P. Concentration of adipogenic proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women. J. Bone Miner. Res., 2010, 25; 492-498.
49. Jiang, X.; Song, D.; Ye, B.; Wang, X.; Song, G.; Shoukang, Y.; Hu, J. Effect of intermittent administration of adiponectin on bone regeneration following mandibular osteodistraction in rabbits. J. Orthop. Res., 2011, 29; 1081-1085.
50. Gonnelli, S.; Caffarelli, C.; Del Santo, K.; Cadirni, A.; Guerriero, C.; Lucani, B.; Franci, B.; Nuti, R. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif. Tissue Int., 2008, 83; 55-60.
51. Michaelsson, K.; Lind, L.; Frystyk, J.; Flyvbjerg, A.; Gedeborg, R.; Berne, C.; Zethelius, B.; Mallmin, H.; Soderberg, S.; Melhus, H. (2008) Serum adiponectin in elderly men does nor correlated with fracture risk. J. Clin. Endocrinol. Metab., 2008, 93; 4041-4047.
52. Basurto, L.; Galván, R.; Cordova, N.; Saucedo, R.; Vargas, C.; Campos, S.; Halley, E.; Avelar, F.; Zárate, A. Adiponectin is associated with low bone mineral density in elderly men. Eur. J. Endocrinol., 2009, 160: 289-293.
53. Araneta, M.R.; von Mühlen, D.; Barrett-Connor, E. Sex differences in the association between adiponectin and BMD, bone loss and fractures: the Rancho Bernardo Study. J. Bone Miner. Res., 2009, 24; 2016-2022.
54. Hong, X.; Arguelles, L.M.; Tsai, H.J.; Zhang, S.; Wang, G.; Wang, B.; Liu, X.; Li, Z.; Tang, G.; Xing, H.; Xu, X.; Wang, X. Plasma adipokines, bone mass, and hip geometry in rural Chinese adolescents. J. Clin. Endocrinol. Metab., 2010, 95; 1644-1652.
55. Bozic, B.; Loncar, G.; Prodanovic, N.; Radojicic, Z.; Cvorovic, V.; Dimkovic, S.; Popovic-Brkic, V. Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure. J. Card. Fail., 2010, 16; 301-307.
56. Frost, M.; Abrahamsen, B.; Nielsen, T.L.; Frystyk, J.; Flyvbjerg, A.; Hagen, C.; Andersen, M.; Brixen, K. Adiponectin and peak bone mass in men: a cross-sectional, population-based study. Calcif. Tissue Int., 2010, 87; 36-43.
57. Iacobellis, G.; Iorio, M.; Napoli, N.; Cotesta, D.; Zinnamosca, L.; Marinelli, C.; Petramala, L.; Minisola, S.; D'Erasmo, E.; Letizia, C. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome. J. Endocrinol. Invest., 2011, 34, e12-15.
58. Loncar, G.; Bozic, B.; Cvorovic, V.; Radojicic, Z.; Dimkovic, S.; Markovic, N.; Prodanovic, N.; Lepic, T.; Putnikovic, B.; Popovic-Brkic, V. Relationship between RANKL and neuroendocrine activation in elderly males with heart failure. Endocrine, 2010, 37; 148-156.
59. Barbour, K.E.; Zmuda, J.M.; Boudreau, R.; Strotmeyer, E.S.; Horwitz, M.J.; Evans, R.W.; Kanaya, A.M.; Harris, T.B.; Bauer, D.C., Cauley, J.A. Adipokines and the risk of fracture in older adults. J. Bone Miner. Res., 2011, 26; 1568-1576.
60. Okuno, S.; Ishimura, E.; Norimine, K.; Tsuboniwa, N.; Kagitani, S.; Yamakawa, K.; Yamakawa, T.; Sato, K.K.; Hayashi, T.; Shoji, S.; Nishizawa, Y.; Inaba, M. Serum adiponectin and bone mineral density in male hemodialysis patients. Osteoporos. Int., Epub ahead of print.
61. Jürimäe, J.; Rembel, K.; Jürimäe, T.; Rehand, M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm. Metab. Res., 2005, 37; 297-302.
62. Jürimäe, J.; Jürimäe, T. Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos. Int., 2007, 18; 1253-1259.
63. Zoico, E.; Zamboni, M.; Di Francesco, V.; Mazzali, G.; Fantin, F.; De Pergola, G.; Zivelonghi, A.; Adami, S.; Bosello, O. Relation between adiponectin and bone mineral density in elderly post-menopausal women : role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J. Endocrinol. Invest., 2008, 31: 297-302.
64. Jürimäe, J.; Jürimäe, T.; Leppik, A.; Kums, T. The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J. Bone Miner. Metab., 2008, 26; 618-623.
65. Kanazawa, I.; Yamaguchi, T.; Yamamoto, M.; Yamauchi, M.; Kurioka, S.; Yano, S.; Sugimoto, T. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab., 2009, 94; 45-49.
66. Jürimäe, J.; Kums, T.; Jürimäe, T. Adiponectin and ghrelin levels in relation to bone mineral density in physically active older women: longitudinal associations. Eur. J. Endocrinol., 2009, 160; 381-385.
67. Wu, N.; Wang, Q.P.; Li, H.; Wu, X.P.; Sun Z.Q.; Luo, X.H. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clin. Chim. Acta., 2010, 411; 771-775.
68. Zhang, H.; Xie, H.; Zhao, Q.; Liao, E.Y.; Xie, G.Q.; Wu, X.P.; Luo, X.H. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in postmenopausal Chinese women. J. Endocrinol. Invest., 2010, 33; 707-711.
69. King, G.A.; Deemer, S.E.; Thompson, D.L. Relationship between leptin, adiponectin, bone mineral density, and measures of adiposity among premenopausal Hispanic and Caucasian women. Endocr. Res., 2010, 35; 106-117.
70. Napoli, N.; Pedone, C.; Pozzilli, P.; Lauretani, F.; Ferrucci, L.; Incalzi, R.A. Adiponectin and bone mass density : The InCHIANTI study. Bone, 2010, 47; 1001-1005.
71. Tenta, R.; Panagiotakos, D.B.; Fragopoulou, E.; Nomikos, T.; Pitsavos, C.; Chrysohoou, C.; Antonopoulou, S.; Stefanadis, C. Osteoprotegerin and nuclear factor-kappaB ligand are associated with leptin and adiponectin levels, in apparently healthy women. J. Musculoskelet. Neuronal. Interact., 2010, 10; 174-179.
72. Jürimäe, J.; Vaiksaar, S.; Mäestu, J.; Purge, P.; Jürimäe, T. Adiponectin and bone metabolism markers in female rowers: eumenorrheic and oral contraceptive users. J. Endocrinol. Invest., 2011, 34, 834-839.
73. Tenta, R.; Kontogianni, M.D.; Yiannakouris, N. Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged postmenopausal women. J. Endocrinol. Invest., 2012, 35, 306-311.
74. Miazgowski, T.; Noworyta-Zietara, M.; Safranow, K.; Ziemak, J.; Widecka, K. Serum adiponectin, bone mineral density and bone turnover markers in post-menopausal women with newly diagnosed type 2 diabetes: a 12-month follow-up. Diabet. Med., 2012, 23, 62-69.
75. Barbour, K.E.; Zmuda, J.M.; Boudreau, R.; Strotmeyer, E.S.; Horwitz, M.J.; Evans, R.W.; Kanaya, A.M.; Harris, T.B.; Cauley, J.A.; The Health ABC Study. The effects of adiponectin and leptin on changes in bone mineral density. Osteoporos. Int., 2012, 23, 1699-1710.
76. Lenchik, L.; Register, T.C.; Hsu, F.C.; Lohman, K.; Nicklas, B.J.; Freedman, B.I.; Langefeld, C.D.; Carr, J.J.; Bowden, D.W. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone, 2003, 33; 646-651.
77. Lee, W.Y.; Rhee, E.J.; Oh, K.W.; Kim, S.Y.; Jung, C.H.; Yun, E.J.; Baek, K.H.; Kang, M.I.; Kim, S.W. Identification of adiponectin and its receptors in human osteoblast-like cells and association of T45G polymorphism in exon 2 of adiponectin gene with lumbar spine bone mineral density in Korean women. Clin. Endocrinol., 2006, 65; 631-637.
78. Tamura, T.; Yoneda, M.; Yamane, K.; Nakanishi, S.; Nakashima, R.; Okubo, M.; Kohno, N. Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism, 2007, 56; 623-628.
79. Bacchetta, J.; Boutroy, S.; Guebre-Egziabher, F.; Juillard, L.; Drai, J.; Pelletier, S.; Richard, M.; Charriė, A.; Carlier, M.C.; Chapurlat, R.; Laville, M.; Fouque, D. The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol. Dial. Transplant., 2009, 24; 3120-3125.
80. Kanazawa, I.; Yamaguchi, T.; Yamauchi, M.; Yamamoto, M.; Kurioka, S.; Yano, S.; Sugimoto, T. Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab., 2009, 94; 3031-3037.
81. Kanazawa, I.; Yamaguchi, T.; Sugimoto, T. Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus. Metabolism, 2010, 59; 1252-1256.
82. Misra, M.; Miller, K.K.; Cord, J.; Prabhakaran, R.; Herzog, D.B.; Goldstein, M.; Katzman, D.K.; Klibanski, A. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa. J. Clin. Endocrinol. Metab., 2007, 92; 2046-2052.
83. Sayers, A.; Timpson, N.J.; Sattar, N.; Deanfield, J.; Hingorani, A.D.; Smith, G.D.; Tobias, J. Adiponectin and its association with bone mass accrual in childhood. J. Bone Miner. Res., 2010, 25; 2212-2220.
84. Dimitri, P.; Wales, J.K.; Bishop, N. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signaling resulting in reduced bone mass. Bone, 2011, 48; 189-196.
85. Tubić, B.; Magnusson, P.; Swolin-Eide, D.; Mårild, S; IDEFICS Consortium. Relation between bone mineral density, biological markers and anthropometric measures in 4-year-old children: a pilot study within the IDEFICS study. Int. J. Obes. (Lond.), 2011, Suppl 1; S119-124.
86. Oh, K.W.; Lee, W.Y.; Rhee E.J.; Baek, K.H.; Yoon, K.H.; Kang, M.I.; Yun, E.J.; Park, C.Y.; Ihm, S.H.; Choi, M.G.; Yoo, H.J.; Park, S.W. The relationship between serum resistin, leptin, adiponectin, ghrelin, levels and bone mineral density in middle-aged men. Clin. Endocrinol. (Oxf.), 2005, 63; 131-138.
87. Chanprasertyothin, S.; Saetung, S.; Payattikul, P.; Rajatanavin, R.; Ongphiphadhanakul, B. Relationship of body composition and circulatory adiponectin to bone mineral density in young premenopausal women. J. Med. Assoc. Thai., 2006, 89; 1579-1583.
88. Biver, E.; Salliot, C.; Combescure, C.; Gossec, L.; Hardouin, P.; Legroux-Gerot, I.; Cortet, B. Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab., 2011, 96; 2703-2713.
89. Samelson, E.J.; Broe, K.E.; Demissie, S.; Beck, T.J.; Karasik, D.; Kathiresan, S.; Kiel, D.P. Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip. J. Clin. Endocrinol. Metab., 2008, 93; 1789-1795.
90. Barrett-Connor, E.; Holbrook, T.L. Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. JAMA, 1992, 268; 3333-3337.
91. Ivers, R.Q.; Cumming, R.G.; Mitchell, P.; Peduto, A.J. Blue Mountains Eye Study: Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care, 2011, 24; 1198-1203.
92. Vestergaard, P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes -a meta-analysis. Osteoporos. Int., 2007, 18; 427-444.
93. Lipscombe, L.L.; Jamal, S.A.; Booth, G.L.; Hawker, G.A. The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care, 2007, 30; 835-841.
94. Strotmeyer, E.S.; Cauley, J.A.; Schwartz, A.V.; Nevitt, M.C.; Resnick, H.E.; Bauer, D.C.; Tylavsky, F.A.; de Rekeneire, N.; Harris, T.B.; Newman, A.B. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch. Intern. Med., 2005, 165; 1612-1617.
95. Saito, M.; Fujii, K.; Mori, Y.; Marumo, K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats. Osteoporos. Int., 2006, 17; 1514-1523.
96. Verhaeghe, J.; Suiker, A.M.; Nyomba, B.L.; Visser, W.J.; Einhorn, T.A.; Dequeker, J.; Bouillon, R. Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology, 1989, 124; 573-582.
97. Gerdhem, P.; Isaksson, A.; Akesson, K.; Obrant, K.J. Increased bone density and decreased bone turnover, but no evident alteration of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos. Int., 2005, 16; 1506-1512.
98. Okazaki, R.; Totsuka, Y.; Hamano, K.; Ajima, M.; Miura, M.; Hirota, Y.; Hata, K.; Fukumoto, S.; Matsumoto, T. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover. J. Clin. Endocrinol. Metab., 1997, 82; 2915-2920.
99. Stein, G.S.; Lian, J.B. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocrin. Rev., 1993, 14; 424-442.
100. Kanazawa, I.; Yamaguchi, T.; Yamamoto, M.; Yamauchi, M.; Yano, S.; Sugimoto, T. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men. Calcif. Tissue Int., 2008, 83; 324-331.
101. Kindblom, J.M.; Ohlsson, C.; Ljunggren, O.; Karlsson, M.K.; Tivesten, A.; Smith, U.; Mellstrom, D. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J. Bone Miner. Res., 2009, 24; 785-791.
102. Fernandez-Real, J.M.; Izquierdo, M.; Ortega, F.; Gorostiaga, E.; Gomez-Ambrosi, J.; Moreno-Navarrete, J.M.; Fruhbeck, G.; Martinez, C.; Idoate, F.; Salvador, J.; Forga, L.; Ricart, W.; Ibanez, J. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J. Clin. Endocrinol. Metab., 2009, 94; 237-245.
103. Kanazawa, I.; Yamaguchi, T.; Yamauchi, M.; Yamamoto, M.; Kurioka, S.; Yano, S.; Sugimoto, T. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos. Int., 2011, 22; 187-194.
104. Kanazawa, I.; Yamaguchi, T.; Tada, Y.; Yamauchi, M.; Yano, S.; Sugimoto, T. Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. Bone, 2011, 48; 270-275.